Andrew Beck
MD, PhD
CEO and Co-founder
👥Biography 个人简介
Andrew Beck co-founded PathAI and has built one of the largest pathology AI platforms leveraging foundation model architectures for cancer and liver disease analysis. His work has advanced AI-powered companion diagnostics and quantitative pathology scoring that support drug development programs. He has demonstrated that foundation model-based pathology AI can improve consistency and accuracy of cancer biomarker assessment in clinical trials.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Andrew Beck 的研究动态
Follow Andrew Beck's research updates
留下邮箱，当我们发布与 Andrew Beck（PathAI）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment